(ARMK) Aramark Holdings - Overview
Sector: Industrials | Industry: Specialty Business Services | Exchange: NYSE (USA) | Market Cap: 11.184m USD | Total Return: 39% in 12m
Industry Rotation: -1.7
Avg Turnover: 97.3M USD
Peers RS (IBD): 85.5
EPS Trend: 51.9%
Qual. Beats: 0
Rev. Trend: 72.8%
Qual. Beats: 1
Warnings
Altman Z'' 0.94 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Aramark (ARMK) provides food and facilities services across diverse sectors including education, healthcare, and sports. The company operates through U.S. and International segments.
The business model centers on managed services. This includes dining, catering, and retail food services. It also encompasses non-clinical support services and facility management services like maintenance and housekeeping. Diversification across multiple client types is common in the contract food service industry.
Additionally, Aramark offers specialized services for correctional facilities, such as food and commissary operations. Understanding the full scope of Aramarks service offerings can be enhanced by further research on ValueRay.
- Client retention and new contract wins drive revenue growth
- Labor costs and food commodity prices impact profitability
- Economic downturns reduce demand for discretionary services
- Regulatory changes in food safety and labor laws pose risks
| Net Income: 316.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.97 > 1.0 |
| NWC/Revenue: 4.14% < 20% (prev -1.15%; Δ 5.29% < -1%) |
| CFO/TA 0.05 > 3% & CFO 726.0m > Net Income 316.9m |
| Net Debt (6.40b) to EBITDA (1.27b): 5.04 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (266.3m) vs 12m ago -0.87% < -2% |
| Gross Margin: 6.98% > 18% (prev 0.08%; Δ 689.9% > 0.5%) |
| Asset Turnover: 143.1% > 50% (prev 138.1%; Δ 5.05% > 0%) |
| Interest Coverage Ratio: 2.20 > 6 (EBITDA TTM 1.27b / Interest Expense TTM 355.0m) |
| A: 0.06 (Total Current Assets 3.63b - Total Current Liabilities 2.86b) / Total Assets 13.54b |
| B: 0.04 (Retained Earnings 515.8m / Total Assets 13.54b) |
| C: 0.06 (EBIT TTM 779.7m / Avg Total Assets 13.12b) |
| D: 0.04 (Book Value of Equity 368.8m / Total Liabilities 10.31b) |
| Altman-Z'' Score: 0.94 = BB |
| DSRI: 1.06 (Receivables 2.50b/2.20b, Revenue 18.79b/17.55b) |
| GMI: 1.19 (GM 6.98% / 8.34%) |
| AQI: 0.97 (AQ_t 0.54 / AQ_t-1 0.56) |
| SGI: 1.07 (Revenue 18.79b / 17.55b) |
| TATA: -0.03 (NI 316.9m - CFO 726.0m) / TA 13.54b) |
| Beneish M-Score: -2.80 (Cap -4..+1) = A |
Over the past week, the price has changed by +3.60%, over one month by +4.17%, over three months by +9.77% and over the past year by +38.99%.
- StrongBuy: 8
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 47.1 | 12.1% |
P/E Forward = 19.084
P/S = 0.5953
P/B = 3.4861
P/EG = 1.0542
Revenue TTM = 18.79b USD
EBIT TTM = 779.7m USD
EBITDA TTM = 1.27b USD
Long Term Debt = 6.21b USD (from longTermDebt, last quarter)
Short Term Debt = 98.8m USD (from shortTermDebt, last quarter)
Debt = 6.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.40b USD (from netDebt column, last quarter)
Enterprise Value = 17.58b USD (11.18b + Debt 6.84b - CCE 439.6m)
Interest Coverage Ratio = 2.20 (Ebit TTM 779.7m / Interest Expense TTM 355.0m)
EV/FCF = 68.37x (Enterprise Value 17.58b / FCF TTM 257.1m)
FCF Yield = 1.46% (FCF TTM 257.1m / Enterprise Value 17.58b)
FCF Margin = 1.37% (FCF TTM 257.1m / Revenue TTM 18.79b)
Net Margin = 1.69% (Net Income TTM 316.9m / Revenue TTM 18.79b)
Gross Margin = 6.98% ((Revenue TTM 18.79b - Cost of Revenue TTM 17.47b) / Revenue TTM)
Gross Margin QoQ = 6.01% (prev 5.78%)
Tobins Q-Ratio = 1.30 (Enterprise Value 17.58b / Total Assets 13.54b)
Interest Expense / Debt = 1.30% (Interest Expense 88.9m / Debt 6.84b)
Taxrate = 28.85% (39.1m / 135.6m)
NOPAT = 554.7m (EBIT 779.7m * (1 - 28.85%))
Current Ratio = 1.27 (Total Current Assets 3.63b / Total Current Liabilities 2.86b)
Debt / Equity = 2.13 (Debt 6.84b / totalStockholderEquity, last quarter 3.21b)
Debt / EBITDA = 5.04 (Net Debt 6.40b / EBITDA 1.27b)
Debt / FCF = 24.87 (Net Debt 6.40b / FCF TTM 257.1m)
Total Stockholder Equity = 3.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.41% (Net Income 316.9m / Total Assets 13.54b)
RoE = 10.17% (Net Income TTM 316.9m / Total Stockholder Equity 3.12b)
RoCE = 8.36% (EBIT 779.7m / Capital Employed (Equity 3.12b + L.T.Debt 6.21b))
RoIC = 6.01% (NOPAT 554.7m / Invested Capital 9.24b)
WACC = 5.75% (E(11.18b)/V(18.02b) * Re(8.70%) + D(6.84b)/V(18.02b) * Rd(1.30%) * (1-Tc(0.29)))
Discount Rate = 8.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.39%
[DCF] Terminal Value 87.48% ; FCFF base≈300.2m ; Y1≈339.8m ; Y5≈461.9m
[DCF] Fair Price = 27.20 (EV 13.55b - Net Debt 6.40b = Equity 7.15b / Shares 262.8m; r=6.0% [WACC]; 5y FCF grow 15.35% → 3.0% )
EPS Correlation: 51.87 | EPS CAGR: 25.13% | SUE: 0.0 | # QB: 0
Revenue Correlation: 72.77 | Revenue CAGR: 6.17% | SUE: 0.97 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=12
EPS current Year (2026-09-30): EPS=2.23 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+4 | Growth EPS=+22.2% | Growth Revenue=+7.0%
EPS next Year (2027-09-30): EPS=2.62 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+5 | Growth EPS=+17.6% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: -0.25 (3 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.9% (Discount Rate 8.7% - Earnings Yield 2.8%)
[Growth] Growth Spread = -0.3% (Analyst 5.6% - Implied 5.9%)